(2021/C 228/17)
Language of the case: English
Appellant: Allergan Holdings France (represented by: T. de Haan, avocat, and J. Day, Solicitor)
Other parties to the proceedings: European Union Intellectual Property Office (EUIPO), Dermavita Co. Ltd
By order of 29 April 2021, the Court of Justice (Chamber determining whether appeals may proceed) held that the appeal was not allowed to proceed and that Allergan Holdings France should bear its own costs.